The Hypertension Recall Gap in Canadian Family Practice

Only 50.9% of Canadian adults with hypertension have their blood pressure both treated and controlled, according to Statistics Canada’s Canadian Health Measures Survey — and the shortfall is not mainly a diagnosis problem (Statistics Canada). It is a follow-up problem: whether the next reading gets booked, whether the patient shows up, and whether anyone in the clinic notices when they don’t. Closing that gap does not require more exam rooms. It requires a recall system that reaches every overdue patient on schedule, without waiting for a receptionist to find a spare hour.

Almost half of treated hypertension in Canada still isn’t controlled

Statistics Canada’s most recent direct measurement — a cuff reading taken as part of the Canadian Health Measures Survey, not a self-report — found that close to one in four Canadian adults aged 20 to 79 meet the clinical threshold for stage 2 hypertension, whether or not a clinician has ever told them so (Statistics Canada). Split that group by awareness, treatment and control, and the picture sharpens considerably.

Just over half of Canadians with stage 2 hypertension are on treatment and at target. The rest split three ways: 16.7% are on medication but still above target, 28.6% don’t yet know they have the condition, and 3.8% know and aren’t being treated (Statistics Canada).

That second bar is worth sitting with. Being unaware is a screening gap, and being aware but untreated is an access gap — but “treated, not controlled” is neither. Those are patients whose clinic already found the problem and already started treatment. What decides whether they end up in the 50.9% or the 16.7% is almost entirely what happens over the following months: whether a follow-up reading gets taken, whether the dose gets adjusted when it should, and whether anyone flags it when a recheck doesn’t happen on time. Prevalence climbs sharply with age too — 3.7% of adults 20 to 39, 22.4% of those 40 to 59, and 51.3% of those 60 to 79 — which means the recall workload concentrates exactly where a family practice’s patient panel is heaviest (Statistics Canada).

Canada used to lead the world on this, and the medicine hasn’t changed

This gap is not new, and it is not inevitable. Canadian hypertension researchers describe the country as having become, by the mid-2000s, “a world leader in hypertension awareness, treatment and control,” built on a coordinated national program that pushed frontline clinicians to measure, treat and recheck blood pressure consistently rather than opportunistically (Journal of Human Hypertension). The same researchers point to national surveillance data showing awareness, treatment and control sliding backward since then, with the decline particularly visible among Canadian women between 2007 and 2017 — and they trace it not to a change in the drugs available, but to a change in the coordinated push that used to keep guideline-driven follow-up consistent across practices (Journal of Human Hypertension).

Read against the Statistics Canada breakdown above, this fits: the country’s edge was never really about medication. Amlodipine and hydrochlorothiazide work the same way in Toronto as they did twenty years ago. What used to be different was the surrounding machinery — the part that turned a diagnosis into an ongoing, checked, adjusted condition instead of a one-time prescription. When that machinery softens at the system level, the same softening shows up, one chart at a time, inside individual clinics.

A scheduled recall doesn’t run itself, even when someone builds one

It would be easy to assume the fix is simply “schedule a follow-up.” A landmark Ontario trial already tested exactly that. Researchers randomised 609 patients with already-controlled hypertension across 50 family practices in southeastern Ontario to either three-month or six-month scheduled follow-up and tracked them for close to three years (BMJ). The interval barely mattered — six-month follow-up was equivalent to three-month follow-up on blood pressure control, patient satisfaction and treatment adherence. But in both arms, roughly one in five patients still had blood pressure that drifted out of target at some point during the study, despite every one of them having a next appointment already booked (BMJ).

That is the drift rate inside a study built specifically to guarantee the recall step happened. Most Canadian family practices are not running anything close to that structure. Whether a treated hypertensive patient actually gets rebooked usually depends on the patient remembering to ask on the way out the door, or a staff member manually flagging a chart weeks later during a quiet afternoon that may or may not arrive. Few practices carry a dedicated recall coordinator role, and fewer still keep a live, auto-updating list of “patients whose last blood pressure reading is more than six months old.”

Staffing your way out of this isn’t realistic right now

It is tempting to conclude that the fix is a dedicated recall coordinator in every practice. For most Canadian clinics, that isn’t a staffing decision available to them. Family physicians per 100,000 population fell from 124 in 2022 to 120 in 2023 to 119 in 2024, and the two years since mark the first stretch since the mid-1990s in which growth in the family medicine workforce fell behind population growth — specialist supply, by contrast, kept growing faster than the population needing specialists (CIHI). A system that is short on family physicians is not about to be flush with spare administrative capacity to run recall lists by hand.

It is hard to consistently practise proactive recall on a manual basis when the same front-desk team is also covering intake calls, billing questions and same-day bookings. A hypertension recall list is exactly the kind of task that gets deprioritized every time a heavier walk-in day hits — which means, in practices without a system for it, the job tends to get done in bursts, like a chart audit ahead of an accreditation review, rather than continuously. A chronic condition that changes month to month needs the opposite of that rhythm. Waiting on patient behaviour to close what is fundamentally a system gap has not worked at the population level, and there is no reason to expect it works better inside one clinic’s booking calendar.

Because each province funds and administers its own health system, the practical shape of this problem looks a little different in Ontario than it does in Alberta or Nova Scotia. The underlying mechanics of a recall gap, though, don’t change with the postal code: a patient’s blood pressure doesn’t know which province is billing for the visit, and it drifts the same way whether the appointment reminder never went out from a clinic in Halifax or one in Calgary.

Building a recall loop that runs on its own

A voice or WhatsApp agent that already holds the recall list — every patient whose last blood pressure check has passed its due date — can work through that list the same way every single week, without waiting for a staff member to find a free hour. It reaches each patient directly, offers the next available slot, confirms or reschedules based on the reply, and only hands the conversation to a person when something genuinely needs clinical judgment.

1. 1
   Flag who is overdue

   Arbol cross-references the practice's hypertension patients against each one's last recorded reading, so nobody depends on a staff member remembering to check a chart.

2. 2
   Reach out on schedule, every week

   A call, text message or WhatsApp message goes out automatically to each overdue patient, on the channel they're most likely to actually respond to.

3. 3
   Confirm or rebook in the same conversation

   The patient picks a slot, confirms, or reschedules right there — no callback tag, no waiting for reception to have a free moment.

4. 4
   Retry automatically on a no-show or no response

   A missed appointment or an unanswered message triggers another attempt on a different day, instead of quietly dropping the patient from the list.

5. 5
   Escalate to the clinical team when it matters

   Reported symptoms, several missed attempts in a row, or a reading that's clearly out of range get routed to a person. The agent runs the routine contact, not the judgment calls.

None of this replaces a clinician’s decision about dose, target or risk — that stays exactly where it belongs. What it replaces is the part of the job that never needed a clinician in the first place: making sure the recall list gets worked every week instead of whenever someone finds the time. Hypertension follow-up is usually the clearest place to start a proactive contact system, because the population is already identified and the interval is already set by clinical practice — the only piece that’s been missing is someone, or something, that reliably runs the list.

That missing piece matters more in Canada than in a system with more slack in it. The same family physician shortage that leaves patients without a regular provider is also why the clinics that do have capacity can’t spare a coordinator to chase recalls by hand — and the same recall mechanics apply just as directly to other conditions that rely on a practice remembering to call the patient back, not only hypertension. If your team is weighing where to build proactive contact first, you can see more about how Arbol works with clinics at getarbol.com.